Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare the efficacy of target Exelon® 10 cm2 patch vs. target Exelon® 15 cm2 patch in patients who have demonstrated cognitive decline in the initial Open-label Treatment Phase (Exelon® 10 cm2 patch) with respect to the change from double-blind randomization baseline to Week 48 of the Double-blind Treatment Phase in cognition as assessed by the total ADAS-Cog score.
Inclusion criteria
- Alzheimer’s disease dementia